Additionally, a subtype of TFRC is positively associated with the infiltration abundances of immune cells in breast cancer, and it is also considered to be a potential target for immunotherapy in breast cancer (Chen et al., 2021) (Corte-Rodríguez et al., 2019). The gene discussed is TFRC; the disease is breast carcinoma.